BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 35994026)

  • 1. Direct incorporation of patient-specific efficacy and toxicity estimates in radiation therapy plan optimization.
    Polan DF; Epelman MA; Wu VW; Sun Y; Varsta M; Owen DR; Jarema D; Matrosic CK; Jolly S; Schonewolf CA; Schipper MJ; Matuszak MM
    Med Phys; 2022 Oct; 49(10):6279-6292. PubMed ID: 35994026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embedding machine learning based toxicity models within radiotherapy treatment plan optimization.
    Maragno D; Buti G; Birbil Şİ; Liao Z; Bortfeld T; den Hertog D; Ajdari A
    Phys Med Biol; 2024 Mar; 69(7):. PubMed ID: 38412530
    [No Abstract]   [Full Text] [Related]  

  • 3. Inverse-optimized 3D conformal planning: minimizing complexity while achieving equivalence with beamlet IMRT in multiple clinical sites.
    Fraass BA; Steers JM; Matuszak MM; McShan DL
    Med Phys; 2012 Jun; 39(6):3361-74. PubMed ID: 22755717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated intensity modulated treatment planning: The expedited constrained hierarchical optimization (ECHO) system.
    Zarepisheh M; Hong L; Zhou Y; Oh JH; Mechalakos JG; Hunt MA; Mageras GS; Deasy JO
    Med Phys; 2019 Jul; 46(7):2944-2954. PubMed ID: 31055858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
    Lee EK; Fox T; Crocker I
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
    Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
    Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced order constrained optimization (ROCO): clinical application to lung IMRT.
    Stabenau H; Rivera L; Yorke E; Yang J; Lu R; Radke RJ; Jackson A
    Med Phys; 2011 May; 38(5):2731-41. PubMed ID: 21776810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized estimates of overall survival in radiation therapy plan optimization - A concept study.
    Modiri A; Stick LB; Rice SR; Rechner LA; Vogelius IR; Bentzen SM; Sawant A
    Med Phys; 2018 Nov; 45(11):5332-5342. PubMed ID: 30246353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
    Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust Optimization of SBRT Planning for Patients With Early Stage Non-Small Cell Lung Cancer.
    Shang H; Pu Y; Wang Y
    Technol Cancer Res Treat; 2020; 19():1533033820916505. PubMed ID: 32314663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.
    Lavrenkov K; Christian JA; Partridge M; Niotsikou E; Cook G; Parker M; Bedford JL; Brada M
    Radiother Oncol; 2007 May; 83(2):156-62. PubMed ID: 17493699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of dose calculation accuracy during optimization on lung IMRT plan quality.
    Li Y; Rodrigues A; Li T; Yuan L; Yin FF; Wu QJ
    J Appl Clin Med Phys; 2015 Jan; 16(1):5137. PubMed ID: 25679172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of a deep reinforcement learning network for dose-volume-constrained treatment planning in prostate cancer intensity modulated radiotherapy.
    Sprouts D; Gao Y; Wang C; Jia X; Shen C; Chi Y
    Biomed Phys Eng Express; 2022 Jun; 8(4):. PubMed ID: 35523130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of biological-based and dose volume-based intensity-modulated radiotherapy plans generated using the same treatment planning system.
    Senthilkumar K; Maria Das KJ
    J Cancer Res Ther; 2019 Mar; 15(Supplement):S33-S38. PubMed ID: 30900617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced optimization of volumetric modulated arc therapy plans using Monte Carlo generated beamlets.
    Mathews J; French SB; Bhagroo S; Pant A; Nazareth DP
    Med Phys; 2020 Dec; 47(12):6053-6067. PubMed ID: 32978967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous optimization of sequential IMRT plans.
    Popple RA; Prellop PB; Spencer SA; De Los Santos JF; Duan J; Fiveash JB; Brezovich IA
    Med Phys; 2005 Nov; 32(11):3257-66. PubMed ID: 16370415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voxel-based automatic multi-criteria optimization for intensity modulated radiation therapy.
    Mai Y; Kong F; Yang Y; Zhou L; Li Y; Song T
    Radiat Oncol; 2018 Dec; 13(1):241. PubMed ID: 30518381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive formulation for volumetric modulated arc therapy planning.
    Nguyen D; Lyu Q; Ruan D; O'Connor D; Low DA; Sheng K
    Med Phys; 2016 Jul; 43(7):4263. PubMed ID: 27370141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hybrid optimization strategy for deliverable intensity-modulated radiotherapy plan generation using deep learning-based dose prediction.
    Sun Z; Xia X; Fan J; Zhao J; Zhang K; Wang J; Hu W
    Med Phys; 2022 Mar; 49(3):1344-1356. PubMed ID: 35043971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis.
    Fleckenstein J; Eschler A; Kremp K; Kremp S; Rübe C
    Radiat Oncol; 2015 Aug; 10():178. PubMed ID: 26292716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.